Actively Recruiting
Study of End-Tidal Carbon Monoxide Levels in Newborns Using Non-Dispersive Infrared Spectroscopy to Help Manage Jaundice
Led by The Fourth Affiliated Hospital of Zhejiang University School of Medicine · Updated on 2026-01-16
100
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying neonatal hyperbilirubinemia, a common condition in newborns causing jaundice. This trial aims to determine the diagnostic threshold of end-tidal carbon monoxide ETCOc, adjusted for ambient CO levels, during the first three days after birth. It also evaluates how well ETCOc measurements using non-dispersive infrared spectroscopy agree with existing research and tests the reliability of this technology for managing neonatal jaundice. The study uses a device called the Erythrocyte Life Span Tester, which employs non-dispersive infrared spectroscopy to measure ETCOc levels in newborns. Measurements are taken at 12, 24, 48, and 72 hours after birth, with each measurement completed within four hours. This approach helps track the dynamic changes in ETCOc concentration during the early neonatal period. Participants will undergo ETCOc assessments at the specified time points. Researchers will analyze the optimal ETCOc threshold values at these intervals and monitor how ETCOc levels vary over time. The study involves newborns who meet specific criteria related to gestational age and birth weight and includes monitoring throughout the first three days of life. The total duration of participation aligns with these early measurements, supporting safe and accurate data collection for jaundice management.
CONDITIONS
Brief Title
Investigation Into the Dynamic Variations of End-Tidal Carbon Monoxide Concentration (ETCOc) in Neonates Utilizing Non-Dispersive Infrared Spectroscopy and Its Implications for Jaundice Management
Research Team
Y
Yixiang Wu
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here